January 30, 2015 1:57 AM ET


Company Overview of Topigen Pharmaceuticals, Inc.

Company Overview

Topigen Pharmaceuticals, Inc., a respiratory biopharmaceutical company, engages in the development of inhaled therapeutics for respiratory disorders. The company focuses on novel and synergistic topical products for asthma, COPD, allergic rhinitis, and associated conditions with unmet therapeutic needs. Its products include TPI ASM8, an inhaled drug for treating multiple inflammatory cytokine receptors, such as asthma; and TPI ARL8, a nasal spray for treating multiple inflammatory cytokine receptors, comprising allergic rhinitis. The company’s products also include TPI 1020, an inhaled nitric-oxide form of budesonide inhibiting neutrophils; and TPI 1100, an inhaled inhibitor of PDEs involved...

2901 Rachel East

Montreal, QC H1W 4A4


Founded in 2000



Key Executives for Topigen Pharmaceuticals, Inc.

Chief Business Officer
Age: 58
Director of Finance
Director of Preclinical Development
Senior Director of Clinical Research
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Worldwide Marijuana Inc. Americas
LEO Pharma Inc. Americas
Ophthalmic Technologies, Inc. Americas
G Production Inc Americas
Duchesnay Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Topigen Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.